BCIRG 006 : docetaxel and trastuzumab-based regimens improve DFS and OS over AC-T in node positive and high risk node negative HER2 positive early breast cancer patients : quality of life (QOL) at 36 months follow-up

• ROBERT NJ

収録刊行物

• J Clin Oncol

  J Clin Oncol 25 18S-, 2007

詳細情報

• CRID: 1570291225642000000
• NII論文ID: 10021288320
• データソース種別:
  • CiNii Articles